Coronary artery disease (CAD) is the most common cause of death and a major cause of hospital
admissions for acute chest pain. In spite of improved treatments still many patients with CAD
have daily attacks of severe chest pain and severely reduced life quality.
The investigators have established a double-blind placebo-controlled trial in patients with
CAD to test efficacy and safety of treatment with adipose derived stem cells to improve
perfusion in the heart muscle and exercise capacity, and reduce the patient's symptoms.